News and Views


Nature Cell Biology 10, 507 - 509 (2008)
doi:10.1038/ncb0508-507

Marked for death

Kevin Petrie1 & Arthur Zelent1

  1. Kevin Petrie and Arthur Zelent are in the Section of Haemato-Oncology, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK.
    e-mail: arthur.zelent@icr.ac.uk


SUMOylation of PML–RARalpha oncoprotein has been linked to its arsenic-induced degradation and the therapeutic response in acute promyelocytic leukaemia. Two groups identify PML as an in vivo target of the RING finger ubiquitin E3 ligase RNF4, which specifically binds polySUMOylated PML and is essential for the arsenic-induced catabolism of both PML and PML–RARalpha.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Search PubMed for

Open Innovation Challenges

naturejobs